ISBN
0-9763428-0-4
Perfect Bound
Acid-Free 6"
x 9" Paperback
117 Pages
5 Illustrations, b&w
Lupus Underground
Includes:
A Reference for
Lupus
UVA1 Phototherapy
Research
1987-2003
$23.95 USA
$29.00 Canada
£13.00 UK
Published by
Hyde
Park Media
FROM LUPUS
UNDERGROUND
Hugh McGrath,
Jr., MD:
“Although joint pain,
photosensitivity,
skin rashes, mouth ulcers, headache, depression and insomnia respond to
UVA1 therapy, the most gratifying response for the patient has been the
loss of fatigue. This observation has heightened our own awareness of
fatigue
as a major source of disability in lupus."
Lynn,
a UVA1 patient for
13
years:
“My energy was
non-existent.
My kids would wake me up, I’d make them breakfast and go back to bed.
They’d
wake me up for lunch, make that, and go back to bed. I couldn’t even
empty
my dishwasher all at one time...At first, the treatments were five days
in a row for three weeks. After the second week, I was a new person. It
was incredible."
Fredrick Urbach,
MD:
“The trouble with UV is
that
most people don’t know what they’re talking about.”
LUPUS/UVA1
Studies/Papers
UPDATES
January 21, 2008
New
York Times Health Guide
Systemic Lupus Erythematosus:
Investigational Treatments
"UVA-1 Phototherapy:
A promising treatment uses
ultraviolet
A-1 (UVA-1) radiation, long UVA wave lengths that do not promote
sunburn
and may actually block inflammatory immune factors..."
February 14, 2008
U.S.
News & World Report
Overabundance of Immune Cells
Might
Trigger Lupus - Study spots overactivity of genes that prevent cell
death
in those
with autoimmune disease
"Researchers from Saint Louis
University report that a pile-up of
superfluous
immune cells might contribute to lupus, a finding which could point to
new therapies for the autoimmune disease."
June 5, 2006
Musculoskeletal
Report
New Treatment for Lupus
Brought
to (UVA-1) Light
"UVA-1 phototherapy can be an
effective
and safe adjuvant therapy to the traditional pharmacological therapies
in SLE patients."
March
7, 2006
Rheumatology
2006;45(6):653-655
Editorial
- Light therapy (with UVA-1) for SLE patients: Is it a good or bad idea?
2006
Lupus,
Vol. 14, No. 10, 859-861 (2005)
Elimination of anticardiolipin antibodies and cessation of cognitive
decline in a UV-A1-irradiated systemic lupus erythematosus patient
April
12, 2005
Rheumatology
2005 44(7):925-931
Ultraviolet-A1
phototherapy modulates Th1/Th2 and Tc1/Tc2 balance in
patients
with systemic lupus erythematosus
"On the
basis
of our study, UVA1 phototherapy does seem to be an effective adjuvant
in
the treatment of SLE patients."
November 11, 2004
Rheumatology.
2004;43:1402-1404
UVA1 Light Useful as
Adjuvant
Therapy for Systemic Lupus Erythematosus
"A new study by Dutch researchers
has
found that UVA1 light therapy significantly decreases validated disease
activity indices in patients with moderately active systemic lupus
erythematosus
(SLE) without causing significant adverse effects."
|
LUPUS
UNDERGROUND
A Chicago reporter
stricken
with lupus gives himself the assignment of finding a way back on his
feet.
After spending nearly 2 1/2 years researching and exactly $4,934.48 on
tanning equipment (that’s right, sun tanning equipment), he files this
report on a long-ignored, drug-free, non-patentable, counter-intuitive
therapy that actually worked -- UVA1 Phototherapy.
FROM
THE INTRODUCTION
If the
demonstrated potential
of UVA1 light to improve the lives of lupus sufferers were more
publicly
known, if research concerning both benefits and risks were accurately
presented,
if critics were fair, if our pharmaceutical industry didn’t hold
excessive
power over medical research and practice...Lupus Underground would
not have needed to be written. If UVA1 light didn’t alleviate fatigue,
it wouldn’t have been.
DOWNLOAD
complete Introduction and
Contents
page
as a PDF.
May
require download of free Adobe
Acrobat Reader
ABOUT
THE AUTHOR
Anthony DeBartolo
is a Chicago-based
journalist who has frequently contributed to the Chicago Tribune.
His feature
work has also appeared in daily newspapers across the U.S. and in
Canada,
including the Baltimore Sun, Chicago Sun-Times, Orlando
Sun-Sentinel,
Sacramento Bee, St. Louis Post-Dispatch and Toronto Star.
BOOK
REVIEW
from
the American Autoimmune Related Diseases Association's newsletter, InFocus,
March 2005:
"Lupus
Underground, by Anthony DeBartolo, is billed as 'a patient’s case
for
a long-ignored drug-free non-patentable counter-intuitive therapy that
actually works.' Readers of the September 2003 issue of InFocus
learned of research being carried out at Louisiana State University by
Hugh McGrath, M.D., in which ultraviolet A-1 light therapy was being
used
to treat lupus patients. DeBartolo, lupus patient and newspaper
reporter,
goes looking to Dr. McGrath and others for the facts behind this
therapy
and, in the process, finds help for his own problems. Sometimes easy to
read, sometimes very technical, but largely encouraging, this is, as
the
author states, 'a reference for lupus UVA1 phototherapy research.' It
is
well referenced – and not your usual lupus book."
|
POST-KATRINA
BOOK
UPDATE
Along
with many
others,
Dr.
McGrath's life
& work in New Orleans were severely disrupted by Hurricane Katrina.
As a result, his Louisiana State University Medical School contact
information
published in Chapter 5, Page 53 is no longer valid.
We
are, however,
very pleased to inform you Dr. McGrath is back at work at a new medical
school.
While
patients with
questions regarding Dr. McGrath's work are encouraged to read this
book,
physicians can contact him directly at this address:
Hugh
McGrath Jr.,
MD
Rheumatology,
Department
of Medicine
Tulane
University
Medical School
SL-57
1430
Tulane Avenue
New
Orleans, LA
70112
|
HOW
TO ORDER LUPUS UNDERGROUND
Via Amazon
( US, UK, Canada, France, Germany and Japan ) as well as Powell's,
and more than a dozen other international retailers including Barnes
&
Noble, Blackwell's, AbeBooks and Alibris
You can also
order
ISBN
0-9763428-0-4
at your local book
store.
|